HIV/AIDS burden, attributable risk factors, and projections among reproductive-age adults in China, 1990-2035: A GBD

Huibo Yan1

  • 1Clinical Laboratory, Shanghai Putuo District Maternity and Infant Hospital, Shanghai, China.

Plos One
|May 27, 2026
PubMed

Insights

China

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • HIV/AIDS remains a significant global health challenge.
  • Antiretroviral therapy has made HIV a manageable chronic condition.
  • Understanding current HIV/AIDS trends in Chinese reproductive-age adults is crucial for epidemic control.

Purpose of the Study:

  • To provide an updated, comprehensive assessment of the HIV/AIDS burden in Chinese reproductive-age adults.
  • To analyze contemporary trends and identify attributable risk factors.
  • To forecast future HIV/AIDS burden using refined methodologies and post-pandemic data.

Main Methods:

  • Extracted age-standardized incidence, prevalence, mortality, and DALYs from GBD 2023 for Chinese adults (15-49 years).
  • Utilized Joinpoint regression for trend analysis and ARIMA models for forecasting to 2035.
  • Analyzed population attributable fractions for unsafe sex, drug use, and intimate-partner violence.

Main Results:

  • Between 1990-2023, age-standardized HIV/AIDS rates increased significantly across all metrics, with males showing steeper rises.
  • Unsafe sex was the primary contributor to HIV/AIDS mortality (70% in 2023).
  • Projections indicate continued female metric increases and widening sex disparities by 2035.

Conclusions:

  • China's HIV epidemic is now a chronic disease burden with significant sex differences.
  • Rising mortality, particularly among women, necessitates gender-differentiated prevention strategies.
  • Findings support China's National HIV/AIDS Action Plan and SDG 3.3 monitoring.
Abstract

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...